

HY-160694 · 50 mg
MedChemExpress · Cat: HY-160694
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/cbu-cit-protac-brd4-degrader-5.html
Description
cBu-Cit-GAL-02-221 is a PROTAC that degrades BRD4 by association with cBu-Cit. cBu-Cit-GAL-02-221 can effectively inhibit BRD4 in HER2 positive and negative breast cancer cell lines. cBu-Cit-GAL-02-221 has a single bond and can be conjugated to an ADC antibody to form a PAC.

